BIOFRONTERA AG NA O.N./ DE0006046113 /
2024-03-28 10:17:37 AM | Chg. -0.004 | Volume | Bid9:58:00 PM | Ask9:58:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.340EUR | -1.16% | 5,680 Turnover: 1,903.200 |
0.303Bid Size: 4,000 | 0.368Ask Size: 8,300 | 19.4 mill.EUR | 0.00% | 0.50 |
Assets
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .3000 | .3000 | .2000 | .3000 | .5000 | ||||||
Intangible Assets | 1.4000 | 1.3000 | 4.3000 | 3.8000 | 3.2000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 1.8000 | 1.5000 | 4.6000 | 4.1000 | 3.7000 | ||||||
Inventories | .1000 | .2000 | .5000 | .9000 | .8000 | ||||||
Accounts Receivable | 0.0000 | 0.0000 | 0.0000 | .3000 | .6000 | ||||||
Cash and Cash Equivalents | 1.4000 | .7000 | .6000 | 3.4000 | 2.9000 | ||||||
Current Assets | 1.6000 | 1.1000 | 1.1000 | 5 | 6 | ||||||
Total Assets | 3.4000 | 2.6000 | 5.7000 | 9 | 9.6000 |
Liabilities
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .6000 | .5000 | .7000 | .7000 | .7000 | ||||||
Long-term debt | 11.3000 | 12.7000 | 10.6000 | 11.2000 | 12 | ||||||
Liabilities to Banks | 12.6000 | 12.7000 | 16.9000 | 11.6000 | 12.4000 | ||||||
Provisions | .5000 | 2.2000 | .5000 | .7000 | .9100 | ||||||
Liabilities | 13.7000 | 15.5000 | 18.2000 | 14.2000 | 14.2000 | ||||||
Share Capital | 7.6000 | 10 | 11.2000 | 16.1000 | 17.8000 | ||||||
Total Equity | -10.4000 | -12.9000 | -12.5000 | -4.1000 | -4.5000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 3.4000 | 2.6000 | 5.7000 | 9 | 9.6000 |
Income Statement
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | .3000 | .4000 | .5000 | 3.4000 | 3.1000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -5.4000 | -6.1000 | -4.4000 | -3.6000 | -7.1000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -3.3000 | -7.7000 | -4.6000 | -4.1000 | -8.1000 | ||||||
Income Taxes | .1000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -3.4000 | -7.7000 | -4.6000 | -4.1000 | -8.1000 |
Per Share
Cash Flow
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -3.7000 | -5.6000 | -4.7000 | -5.2000 | -7.7000 | ||||||
Cash Flow from Investing Activities | .4000 | 0.0000 | -.3000 | -.1000 | -.3000 | ||||||
Cash Flow from Financing | 4.5000 | 4.9000 | 4.8000 | 8.1000 | 7.6000 | ||||||
Decrease / Increase in Cash | 1.3000 | -.7000 | -.1000 | 2.8000 | -.4000 | ||||||
Employees | 23 | 20 | 27 | 34 | 38 |